Palisade Share Price

Palisade Share Price

NASDAQ: PALI | Micro Cap | Healthcare
$0.96
-$0.05 (-4.76%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Palisade Stock Performance

Open
$1.00
Prev. Close
$1.01
Circuit Range
N/A
Day Range
$0.94 - $1.00
Year Range
$0.94 - $2.85
Volume
2,21,378
Average Traded
$0.97

Palisade Share Price Today

As of 19 November 2026, Palisade Bio, Inc.'s share price is $0.96. The stock opened at $1.00, compared to its previous close of $1.01. During today's trading session, Palisade Bio, Inc.'s share price traded between $0.94 and $1.00, with an average price of $0.97. Over the past 52 weeks, the stock has recorded a high of $2.85 and a low of $0.94. In terms of performance, Palisade Bio, Inc.'s share price has declined by 54.84% over the last six months and is down 54.30% on a year-on-year basis.

Palisade Share Price Chart

Line chart of the Palisade price trend over the selected period. The price fell overall, ranging from 0.94 to 1.00, ending at 0.96.
$0.94$1.00
L
Show Current Price
H

Palisade Stock Fundamentals & Key Indicators

Market Cap
$53.55M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.24
Revenue (TTM)
$0.00
Return On Equity (TTM)
-38.86%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-64.27%

Palisade Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.50$0.00
Net Profit-$8.90-$9.60-$10.57-$14.62
Net Profit MarginN/AN/A-2114.00%N/A
Income ChangeN/A-7.87%-10.10%-38.32%

Palisade Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.25$0.00$0.00
Net Profit-$14.55-$12.32-$14.44-$16.78
Net Profit MarginN/A-4928.00%N/AN/A
Income ChangeN/A15.33%-17.21%-16.20%

Palisade Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.120.390.721.03
Current Assets134.2210.4913.3314.73
Total Assets134.3410.8814.0515.76
Non Current Liabilities0.330.150.150.27
Current Liabilities4.643.242.593.01
Total Liabilities4.963.392.743.28
Shareholders' Equity129.387.4911.3112.48

Palisade Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-10.85-12.19-11.13-13.36
Investing0.00.00.0-0.01
Financing134.449.5811.1915.26

Corporate Actions

Split
Ex-date: 08 Apr 2024

Split
Ex-date: 16 Nov 2022

Split
Ex-date: 18 Jul 2019

About Palisade

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Palisade Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.19
$0.96
-17.86%
Oct 2026
$1.37
$1.17
-12.36%
Sep 2026
$1.98
$1.33
-36.73%
Aug 2026
$1.90
$2.11
+11.35%
Jul 2026
$2.13
$1.90
-10.19%
Jun 2026
$2.12
$2.11
-0.94%
May 2026
$1.97
$2.13
+7.04%
Apr 2026
$1.76
$1.99
+13.71%
Mar 2026
$1.75
$1.75
-1.41%
Feb 2026
$1.49
$1.77
+18.33%
Jan 2026
$2.40
$1.50
-36.44%
Dec 2025
$2.03
$2.36
+12.11%

Palisade Share Price FAQs